home All News open_in_new Full Article
Ingresos y beneficios se disparan pero sus acciones se hunden: por qué los mercados castigan a Novo Nordisk y a Lilly
today 4 d. ago attach_file Politics
attach_file
Sport
attach_file
Events
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
ID: 4138501410